CLOVES syndrome. First case reported in Colombia.

Main Article Content

Johana Katerine Penagos Ruiz
Adriana Isabel Agamez Diaz
Ornella Ruiz Pérez
Zaryla Esther Palacio Conrado
Henry J González Torresa

Abstract

Background: CLOVES syndrome is a rare, non-inherited genetic disorder characterized by overgrowth of any part of the body, vascular malformations, bone defects, and changes in skin color. Case report: a clinical case of CLOVES Syndrome in Barranquilla (Colombia) is presented. A nineteen-month-old female patient from Venezuela, without prior evaluations by specialists in the country of origin or residence. She comes for the first time due to feed intolerance; the overgrowth lesions were observed in this evaluation. Medical management was provided with immediate discharge due to non-affiliation with a Health Services Provider Company. Three months later, with the support of the interdisciplinary group of complex vascular anomalies (GIAV) in Buenos Aires (Argentina), the clinical diagnosis of CLOVES syndrome was made. A meeting of specialties was scheduled to start treatment. The patient died three days before the meeting due to complications associated with gastroenteritis and dehydration. Conclusions: In the case presented, it is a syndrome with overgrowth of the limbs at an early age and presents gastrointestinal complications occasionally. The diagnosis was made thanks to the collaboration of the GIAV of the Garrahan Hospital, who confirmed that the patient met all the clinical criteria. It was not possible to carry out specific therapeutic interventions due to problems of availability of the health service, with a fatal outcome three months after diagnosis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Penagos Ruiz , J. K. ., Agamez Diaz, A. I., Ruiz Pérez , O., Palacio Conrado , Z. E., & González Torresa, H. J. (2022). CLOVES syndrome. First case reported in Colombia. Pediatría, 54(Suplemento 1), 22–27. https://doi.org/10.14295/rp.v54iSuplemento1.382
Section
Case report

References

Russo S, Calzari L, Mussa A, Mainini E, Cassina M, Di Candia S, et al. A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-Russell and Beckwith-Wiedemann syndromes. Clin Epigenetics. 2016;8:23. DOI: https://doi.org/10.1186/s13148-016-0183-8

P. Lapunzina, J. Tenorio. Sobrecrecimiento corporal asimétrico localizado (hemihipertrofia/hemihiperplasia): nomenclatura, definición, epidemiología y clínica, Pediatr Integral 2019;XXIII(5):258–261.

Martínez-Frías M, Bermejo E, Martínez-Fernández ML. Síndrome de CLOVE(S): Características y Guía diagnóstica, Estudio Colaborativo Español de Malformaciones Congénitas (ECEMC). 2010; 23.

Fajre X, Britzmann J, Whittle C, Vargas. P. Síndrome de CLOVES. Rev chilena Dermatol. 2014;30:209-11.

Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol. 2009;18(1):1-7. DOI: https://doi.org/10.1097/MCD.0b013e328317a716

Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet. 2007;143A:2944–2958. DOI: https://doi.org/10.1002/ajmg.a.32023

Kurek KC, Luks VL, Ayturk UM, Alomari A, Fishman S Spencer S et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90:1108–1115. DOI: https://doi.org/10.1016/j.ajhg.2012.05.006

Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A (2):287-95. DOI: https://doi.org/10.1002/ajmg.a.36836

Gucev ZS, Tasic V, Jancevska A, Konstantinova MK, Pop-Jordanova N, Trajkovski Z, Biesecker LG. Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder. Am J Med Genet A. 2008;146A:2688-90. DOI: https://doi.org/10.1002/ajmg.a.32515

Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P, Bonnet F, Selma ZB, Laroche L, Gérard M, Longy M. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet. 2007;15:767-73. DOI: https://doi.org/10.1038/sj.ejhg.5201823

Alomari AI, Chaudry G, Rodesch G, Burrows PE, Mulliken JB, et al. Complex spinal-paraspinal fast-fl ow lesions in CLOVES syndrome: analysis of clinical and imaging fi ndings in 6 patints. AJNR Am J Neuroradiol. 2011;32(10):1812-1817. DOI: https://doi.org/10.3174/ajnr.A2349

Bloom J, Upton J, 3rd. CLOVES syndrome. J Hand Surg Am. 2013;38(12):2508-12. DOI: https://doi.org/10.1016/j.jhsa.2013.08.120

Alomari AI. Comments on the diagnosis and management of CLOVES syndrome. Pediatr Dermatol. 2011;28(2):215-216. DOI: https://doi.org/10.1111/j.1525-1470.2011.01396.x

Martínez-Frías ML, Bermejo E, Martínez-Fernández ML. Síndrome de CLOVE(S): Características y Guía diagnóstica. PROPOSITUS. 2010;23.

Maclellan RA, Luks VL, Vivero MP, Mulliken JB, Zurakowski D, Padwa BL, et al. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg. 2014;133(1):12e-9e. DOI: https://doi.org/10.1097/01.prs.0000436822.26709.7c

Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovee JV, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J. Pediatr. 2015;166(4):1048-54 e1-5. DOI: https://doi.org/10.1016/j.jpeds.2014.12.069

Triana P, Dore M, Cerezo VN, et al. Sirolimus in the Treatment of Vascular Anomalies. Eur J Pediatr Surg. 2017;27:86-90.

Renatta de Graziaa, Consuelo Giordanob, Laura Cossioc, Camila Downeyc, Ángela Delucchid, Daniela Kramer. Síndrome de CLOVES: Tratamiento con Rapamicina oral. Reporte de dos casos. Rev Chil Pediatr. 2019;90(6):662-667. DOI: 10.32641/rchped. v90i6.1025. DOI: https://doi.org/10.32641/andespediatr.v90i6.1025

Adams DM, Trenor CC 3rd, Hammill AM, et al. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Pediatrics. 2016;137(2):e20153257. DOI: https://doi.org/10.1542/peds.2015-3257

Klippel M, Trenaunay P. Arch Gen Med 1900:185: 641–672. 5. Klippel Trenaunay-Weber syndrome [Internet]. 2019 [consultado en abril 18 de 2020]. Disponible en: https://www.omim.org/entry/149000?search=klippel&highlight=klippel.

Cohen MM. Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet. 2014;85:111–9. DOI: https://doi.org/10.1111/cge.12266

Reference N. Klippel-Trenaunay syndrome. Genetics Home Reference. 2019 [consultado en abril 18 de 2020]. Disponible en: https://ghr.nlm.nih.gov/condition/klippel-trenaunay-syndrome.

Mares-Chiyón A y Cols. Síndrome de Cloves: Reporte de un Caso y Revisión de los Diagnósticos Diferenciales. Rev. argent. dermatol. 2020;101 (2): 57 – 64. DOI: https://doi.org/10.35366/95047

Most read articles by the same author(s)

Similar Articles

<< < 2 3 4 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.